Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment

Retina. 2012 Apr;32(4):799-804. doi: 10.1097/IAE.0b013e31823d8e1e.

Abstract

Purpose: To study the effect of intraarterial chemotherapy (IAC) on retinoblastoma-induced retinal detachment.

Methods: Retrospective, noncomparative, interventional case series including 15 patients, with intraarterial (ophthalmic artery) chemotherapy as the intervention. Resolution of retinal detachment was the main outcome measure.

Results: Of 15 patients with retinoblastoma-induced retinal detachment managed with IAC, 7 (47%) presented with total retinal detachment and 8 (53%) with partial detachment. The eyes were classified as International Classification of Retinoblastoma group C (n = 2, 13%), group D (n = 4, 27%), and group E (n = 5, 33%). There were 4 eyes (27%) that received IAC as secondary treatment after the failure of other treatment methods. After IAC, all tumors showed regression. Of the 7 eyes with initial total retinal detachment, complete resolution of fluid was found in 3 (43%) and partial resolution in 4 (57%). Of the 8 eyes with initial partial retinal detachment, complete resolution of subretinal fluid was found in all 8 (100%), but 1 eye later developed recurrent subretinal fluid. The mean interval to complete resolution of subretinal fluid was 2 months. Globe salvage was achieved in 5 of 7 eyes (71%) with total retinal detachment and 6 of 8 eyes (75%) with partial retinal detachment.

Conclusion: Eyes with retinoblastoma-induced total or partial retinal detachment showed complete resolution of detachment after IAC in 43% and 100%, respectively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Injections, Intra-Arterial
  • Male
  • Retinal Detachment / drug therapy*
  • Retinal Detachment / etiology
  • Retinal Neoplasms / complications
  • Retinal Neoplasms / drug therapy*
  • Retinoblastoma / complications
  • Retinoblastoma / drug therapy*
  • Retrospective Studies

Substances

  • Antineoplastic Agents